MONTVALE, N.J., May 4 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY) announced today that it will report its first quarter
2006 financial results on Thursday, May 11, 2006, before the U.S. financial
markets open. Management will provide a Company update and discuss the first
quarter results during a conference call on Thursday, May 11, 2006, at 9:00
a.m. EDT. Jim Sulat, President and Chief Executive Officer, and Dr. David
Lowe, Chief Scientific Officer will host the conference call.
Investors and other interested parties may access the call as follows:
Date: Thursday, May 11, 2006
Time: 9:00 a.m. EDT
Telephone (U.S.): 866.203.3436
Telephone (international): 617.213.8849
Participant Passcode: 59889999
Webcast: http://www.memorypharma.com
under the "Investors" section
An audio replay of the conference call will be available from 11:00 a.m.
EDT on Thursday, May 11, 2006, until Thursday, May 18, 2006. To access the
replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and
enter pass code number 12047110. An audio replay of the conference call will
also be available under the "Investors" section of the Company's website
during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 05/04/2006
/CONTACT: Jzaneen Lalani, Vice President, Legal Affairs of Memory
Pharmaceuticals Corp., +1-201-802-7249; or Laura Perry of Stern Investor
Relations, Inc., +1-212-362-1200/
/Web site: http://www.memorypharmaceuticals.com /
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey
IN: HEA MTC BIO
SU: CCA MAV
AS
-- NYTH198 --
3962 05/04/2006 17:13 EDT http://www.prnewswire.com
